<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35544635</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1972-2680</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>30</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of infection in developing countries</Title>
          <ISOAbbreviation>J Infect Dev Ctries</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Challenges of the treatment of pediatric hepatosplenic bartonellosis: case report and literature review.</ArticleTitle>
        <Pagination>
          <StartPage>712</StartPage>
          <EndPage>716</EndPage>
          <MedlinePgn>712-716</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3855/jidc.15042</ELocationID>
        <Abstract>
          <AbstractText>The hepatosplenic (HS) form of cat scratch disease (CSD) is rarely seen; however, management of the treatment is challenging for clinicians. Monotherapy or combination regimens may be preferred based on severity of cases. Along with that, there are uncertainties as to the combination and duration of antibiotics effective against the microorganisms. In this report, a 12-year-old girl diagnosed with HS-CSD and unresponsive to primary treatment with macrolide group antibiotic was presented. The patient had liver findings compatible with CSD, confirmed radiologically and pathologically, and Bartonella henselae indirect immunofluorescence assay IgG was positive at 1/2048 titre. A combination therapy for six months with doxycycline and rifampicin was initiated, and the patient was successfully treated. The preference for monotherapy or combination regimen in HS-CSD is predominantly determined by the clinician according to the severity of the patient's clinical findings. The effectivity of antimicrobial regimen in HS-CSD requires further investigation.</AbstractText>
          <CopyrightInformation>Copyright (c) 2022 Saliha Kanik-Yuksek, Belgin Gulhan, Selen Hurmuzlu, Aslınur Ozkaya-Parlakay, Altan Gunes, Ayse Selcen Oguz-Erdogan, Hasan Tezer.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kanık-Yüksek</LastName>
            <ForeName>Saliha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Infectious Diseases Department, University of Health Sciences, Ankara City Hospital, Ankara, Turkey. salihakanik@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gülhan</LastName>
            <ForeName>Belgin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Infectious Diseases Department, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hürmüzlü</LastName>
            <ForeName>Selen</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Diseases Department, University of Health Sciences, Ankara City Hospital, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Özkaya-Parlakay</LastName>
            <ForeName>Aslınur</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Infectious Diseases Department, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Güneş</LastName>
            <ForeName>Altan</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Radiology Department, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oğuz-Erdoğan</LastName>
            <ForeName>Ayşe Selcen</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Pathology Department, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tezer</LastName>
            <ForeName>Hasan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Infectious Diseases Department, Gazi University Medical Faculty, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>J Infect Dev Ctries</MedlineTA>
        <NlmUniqueID>101305410</NlmUniqueID>
        <ISSNLinking>1972-2680</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018416" MajorTopicYN="Y">Bartonella henselae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002372" MajorTopicYN="Y">Cat-Scratch Disease</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019084" MajorTopicYN="N">Fluorescent Antibody Technique, Indirect</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bartonellosis</Keyword>
        <Keyword MajorTopicYN="N">hepatosplenic</Keyword>
        <Keyword MajorTopicYN="N">treatment</Keyword>
      </KeywordList>
      <CoiStatement>No Conflict of Interest is declared</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>14</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35544635</ArticleId>
        <ArticleId IdType="doi">10.3855/jidc.15042</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
